Lifecome Biochemistry Co.,Ltd. (SHE:002868)
18.85
+0.56 (3.06%)
Nov 5, 2026, 3:04 PM CST
Lifecome Biochemistry Revenue
Lifecome Biochemistry had revenue of 98.49M CNY in the quarter ending September 30, 2026, a decrease of -14.95%. This brings the company's total for the last twelve months to 453.12M, down -22.81% year-over-year. In the year 2025, Lifecome Biochemistry had annual revenue of 516.58M, down -20.45%. That makes Lifecome Biochemistry the 25,663rd largest company in the world by revenue and 4,549th in China.
Revenue (ttm)
453.12M
Revenue Growth
-22.81%
P/S Ratio
6.47
Revenue / Employee
825.35K
Employees
549
Market Cap
2.93B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Lifecome Biochemistry breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 516.58M | -132.79M | -20.45% |
| Dec 31, 2024 | 649.37M | 142.37M | 28.08% |
| Dec 31, 2023 | 507.00M | 177.15M | 53.71% |
| Jan 1, 2023 | 329.85M | -33.54M | -9.23% |
| Dec 31, 2021 | 363.39M | 55.24M | 17.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xiangxue Pharmaceutical | 1.51B |
| Qingdao Vland Biotech INC. | 1.45B |
| Kexing Biopharm | 1.30B |
| Beijing Kawin Technology Share-Holding | 1.21B |
| Pulike Biological Engineering | 1.00B |
| Landfar Bio-medicine | 748.74M |
| Hubei Goto Biopharm Group | 665.71M |
| Zhejiang Shouxiangu Pharmaceutical | 590.94M |